Dave Wallace, Generics Bulletin executive editor (@davegenerics) 's Twitter Profile
Dave Wallace, Generics Bulletin executive editor

@davegenerics

Generics Bulletin editor Dave Wallace looks at everything that's important to the generics, biosimilars and value-added medicines industries. All views my own.

ID: 1106128939427205120

linkhttps://pharmaintelligence.informa.com/ calendar_today14-03-2019 09:44:24

129 Tweet

131 Takipçi

120 Takip Edilen

Dave Wallace, Generics Bulletin executive editor (@davegenerics) 's Twitter Profile Photo
Dave Wallace, Generics Bulletin executive editor
@davegenerics

3 years ago

In this exclusive two-part interview, Amgen 🧪🔬🧬's Chad Pettit, Amgen Biosimilars commercial lead, talks to Generics bulletin about the firm’s “unique perspective” on biosimilars, including how competition to Humira is expected to signal a major shift in the US biosimilars landscape.